Eagle IP was honored to co-host the AIPLA Women in IP Global Networking Event in collaboration with the Hong Kong Science and Technology Parks Corporation (HKSTP).

This annual event, organized by the American Intellectual Property Law Association (AIPLA), took place simultaneously in over 40 cities worldwide. As the official Hong Kong host, Eagle IP welcomed a vibrant community of female leaders, innovators, entrepreneurs, and IP practitioners to the Science Park for an evening of shared experiences and professional growth.

We would like to thank HKSTP for their partnership and all the attendees who contributed to such an inspiring evening. At Eagle IP, we are proud to support the advancement of women in the field and look forward to continuing these vital conversations.

Our Past Events

Recommended Insights

CHINA: New Patent Examination Guidelines Now Available for Public Comment

4 August 2021
Two months after the new Chinese Patent law came into effect, the CNIPA has released a new set of Patent Examination Guidelines (proposed version) for public comments on Aug 3, 2021. Here are the explanation of the amendments (Chinese only). Here is the full set of proposed amendments (Chinese only). Briefly, the new amendment focuses […]

Connecting the Dots: China’s Evolving Standard for Numerical Sub-Range Amendments

22 July 2026
Managing global pharmaceutical or chemical portfolios requires navigating China’s notoriously rigid standards on the "same subject matter" requirement for priority and claim amendments. A recent invalidation decision (No. 588094) issued by the China National Intellectual Property Administration (CNIPA) concerning a pharmaceutical patent provides clarity on how numerical ranges and later added experimental data are evaluated […]

Foreigners Beware: China Proposes Requiring IP Made Using Exported Chinese Genetic Resources to be Co-Owned by Chinese Collaborators

22 March 2023
Proposed Examination Guidelines for the New Chinese Patent Law – Topic 2: Genetic Resource Restriction How Will the Tightened Genetic Resource Restrictions Affect Your IP In 2019-2021, China’s Ministry of Science and Technology (“MOST”, or the Science Ministry) established several laws and regulations with respect to biosafety1 and human genetic resources management2 (collectively referred as […]

Is it Sufficient to Claim an Antibody only by Describing its Antigen?

12 November 2018
Things may be brewing with respect to antibody inventions. Just how much description is sufficient? After losing in the Federal Circuit, Amgen has decided to ask the US Supreme Court to weigh in on a standard that could vastly influence the pharmaceutical and biotech industry. The story relates to Repatha™, an LDL-lowering drug from Amgen […]
Top crossarrow-right